Tech Company Financing Transactions
Newcells Biotech Funding Round
On 2/14/2024, Newcells Biotech raised $3 million in funding from European regional development fund, Mercia Ventures and North East Venture Fund.
Transaction Overview
Company Name
Announced On
2/14/2024
Transaction Type
Venture Equity
Amount
$2,966,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to boost its growth and help establish itself as a player in its field.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
The Biosphere Drayman's Way Newcastle Helix
Newcastle upon Tyne, NE4 5BX
UK
Newcastle upon Tyne, NE4 5BX
UK
Phone
Website
Email Address
Overview
Newcells Biotech provides clients with validated in vitro tools to understand how drugs interact with tissues. We enable the generation of robust and informative data to support critical decisions during any stage of drug-development. We believe that improving the in vitro models available to drug discovery and development scientists is a key method for increasing the efficiency of in-vitro to in-vivo translation and ultimately to delivering new therapies to patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mike Nicholds
Chief Scientific Officer
Lyle Armstrong
Chief Technical Officer
Colin Brown
VP - Bus. Development
David Hutchings
VP - Finance
Simon Berry
VP - Operations
Richard Strike
Browse more venture capital transactions:
Prev: 2/14/2024: Kema venture capital transaction
Next: 2/14/2024: Boat Planet venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs